BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Unlocking the Potential of Targeting the Innate Immune System\
 n\nAfter years of rigorous research and foundational progress\, the infla
 mmasome drug development field is reaching a critical inflection point. W
 ith long-awaited clinical data now beginning to emerge\, momentum is buil
 ding\, and the landscape is evolving rapidly. NodThera has shared encoura
 ging results in Parkinson’s disease and obesity\, Ventus has initiated a 
 Phase IIa clinical trial\, and Ventyx is progressing a diversified pipeli
 ne of inflammasome-targeting assets. As the race for first-in-class succe
 ss accelerates\, the field stands on the cusp of transformative breakthro
 ughs.\n\nNow in its 7th year\, the Inflammasome Therapeutics Summit remai
 ns the only industry event dedicated exclusively to inflammasome-targeted
  drug development. Bringing together over 70 leading drug developers\, tr
 anslational scientists\, and clinical experts\, this summit offers a uniq
 ue platform to exchange insights\, benchmark clinical progress\, and shap
 e the next chapter of therapeutic innovation.\n\nAcross neuroinflammation
 \, metabolic disorders\, and autoimmune diseases\, this meeting will expl
 ore the most current clinical data\, emerging strategies\, and scientific
  advances. Join your peers to hear directly from those driving programs f
 orward\, tackle the most pressing translational challenges\, and help cha
 rt the future of inflammasome therapeutics.\n\n&nbsp\;\n\nTime: 9:00 AM -
  5:00 PM\n
DTEND:20251106T170000
DTSTAMP:20260512T220025Z
DTSTART:20251104T090000
LOCATION:Hotel Commonwealth\, 500 Commonwealth Avenue\, Boston\, Massachus
 etts\, 02215\,
SEQUENCE:0
SUMMARY:Unlocking the Potential of Targeting the Innate Immune System\nAft
 er years of rigorous research and foundational progress\, the inflammasom
 e drug de...
UID:187e571d-5eaf-4679-a9e4-8a131be48490
END:VEVENT
END:VCALENDAR